-
Dabrafenib
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Dabrafenib -
Aprocitentan
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Aprocitentan -
Etrasimod
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Etrasimod Ulceratuve Colitis(UC) Arena(Pfizer) Maehe05,2030 -
Tirzepatide
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Tirzepatide Te mate huka momo 2, ka ngaro te taumaha Eri Lilly Hanuere05,2036 -
Semaglutide
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Semaglutide Te mate huka momo 2, ka ngaro te taumaha Novo Nordisk Tihema 05,2031 -
Oteseconazole
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Oteseconazole Whakaitihia te reiti o te candidiasis vulvovaginal auau
MycoviaPharmaceuticals Apr.22,2031 -
Finerenone
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Finerenone Nephropathy mate huka Bayer Apr.12,2029 -
Vibegron
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Vibegron OAB Urovant Tihema 01,2030 -
Capivasertib
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Capivasertib mate pukupuku uma AstraZeneca Maehe 10.2030 -
Resmetirom
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Resmetirom NASH Roche Hepetema12,2026 -
Darolutamide
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Darolutamide maimoatanga mate pukupuku prostatic Bayer Maehe 25,2033 -
Upadacitinib
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Upadacitinib Dermatitis Atopic ABBVIE INC Tihema 01,2030